Additionally, MMP13 is also capable of degrading aggrecan and proteoglycan, suggesting it has a dual role in ECM destruction in RA (Burrage et al., 2006; Takaishi et al., 2008). The gene discussed is ACAN; the disease is rheumatoid arthritis.